Skip to main content
Clinical Trials/NCT06720740
NCT06720740
Withdrawn
Not Applicable

The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux

University of California, San Diego0 sites50 target enrollmentDecember 1, 2024

Overview

Phase
Not Applicable
Intervention
Standard of Care Ureteral Stent
Conditions
Kidney Stone
Sponsor
University of California, San Diego
Enrollment
50
Primary Endpoint
Retrograde urine reflux
Status
Withdrawn
Last Updated
2 months ago

Overview

Brief Summary

Assessment of the backwards flow of urine from the bladder into the ureter (retrograde urine reflux) after placement of the RELIEF® Ureteral Stent using imaging of the bladder after filling it with contrast and assigning a urinary reflux grade. Randomized controlled trial for evaluation of the stent placement and the adequacy of short term drainage (defined as the presence of the stent in the ureter and the lack of surgical or standard of care double J stent to treat symptoms associated with the stent itself on the stented side during the first 48 hours).

Registry
clinicaltrials.gov
Start Date
December 1, 2024
End Date
December 31, 2025
Last Updated
2 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Seth Bechis

Associate Professor of Urology

University of California, San Diego

Eligibility Criteria

Inclusion Criteria

  • Has capacity to consent
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Persons, 18 years of age or older
  • Male or female subjects with confirmed ureteral and/or renal stones or strictures documented via abdomen X-ray KUB (kidney ureter bladder) or CT (computed tomography)

Exclusion Criteria

  • Distal ureteral obstruction where suture portion of stent may be placed
  • Urinary reflux (assessed by pre-stent cystogram)
  • Pregnancy or lactation
  • Patients requiring bilateral surgical stone management procedure
  • Infected stones
  • Patients where 24cm or 26cm stent lengths are not suitable
  • Ureteral structure in distal third of ureter
  • Intraoperative exclusion: based on urologist's discretion, if trauma has been induced to the distal ureter due to ureteroscopy maneuvers, exclude these patients

Arms & Interventions

Standard of Care Ureteral Stent

Intervention: Standard of Care Ureteral Stent

RELIEF Ureteral Stent

Intervention: RELIEF Ureteral Stent

Outcomes

Primary Outcomes

Retrograde urine reflux

Time Frame: At time of stent placement - Day 0, and through study completion - an average of 12 weeks post-operatively

Assessment of retrograde urine reflux after placement of a ureteral stent using cystography after contrast gravity-filling of the bladder and assigning a urinary reflux grade based on standard scoring.

Secondary Outcomes

  • Stent symptoms(Up until stent removal - Day 7-14, and through study completion - and average of 12 weeks post-operatively)

Similar Trials